(Alliance News) - Stock prices in London opened mixed on Tuesday, with the FTSE 100 underperforming, as a more positive mood prevailed elsewhere. Read More
(Alliance News) - European equities closed higher on Friday, clawing back some losses at the end of a week which saw post-new year optimism in stock markets give way to caution. Read More
(Alliance News) - AstraZeneca PLC on Monday said it completed its acquisition of Neogene Therapeutics Inc, a clinical-stage biotechnology company focused on the discovery, development and manufacturing of T-cell receptor therapies. Read More
(Alliance News) - With US financial markets closed for a public holiday on Monday and after better-than-expected data for the UK economy on Friday, stocks in London were set to start the week slightly higher. Read More
(Alliance News) - AstraZeneca PLC on Friday said Tezspire has been approved for self-administration in the EU in a new pre-filled pen, for severe asthma patients aged 12 years and older. Read More
(Alliance News) - AstraZeneca PLC unveiled its first acquisition of the year on Monday, forking out just shy of USD2 billion for a buy which could ease pressure on its cardiorenal arm amid an upcoming loss of exclusivity. Read More
(Alliance News) - AstraZeneca PLC on Monday said it has acquired CinCor Pharma Inc for an upfront cash consideration of around USD1.3 billion, though the fee could rise to USD1.8 billion. Read More
(Alliance News) - London's FTSE 100 was called to start the new week higher, after a strong handover from Asia on Monday and a bullish end to the first week of the year in New York. Read More
(Alliance News) - AstraZeneca PLC and its partner Sanofi SA on Thursday said nirsevimab, their antibody against respiratory syncytial virus, has been approved for review by the US Food & Drug Administration for preventing RSV lower respiratory tract disease in newborns and infants up to 24 months of age. Read More
(Alliance News) - Stock prices in London were higher at midday on Wednesday, with sentiment remaining upbeat as investors looked to the year-end after the Christmas break. Read More
